CIK 0001534969
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261911522
- Phone
- +1 801-990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- 4 Open-market sale Chief Data Officer sold 4,078 shares at $7.32 ($29,851)
- 4 Open-market sale General Counsel sold 4,727 shares at $7.32 ($34,602)
- 4 Open-market sale Chief Information Officer sold 4,727 shares at $7.32 ($34,602)
- 4 Open-market sale Chief Scientific Officer sold 4,727 shares at $7.32 ($34,602)
- 4 Open-market sale Chief Financial Officer sold 7,179 shares at $7.32 ($52,550)
- 4 Open-market sale Director sold 96 shares at $7.15 ($686)
- 4 Open-market sale Chief Financial Officer sold 5,056 shares at $7.57 ($38,274)
- 4 Open-market sale Chief Executive Officer sold 25,085 shares at $7.57 ($189,893)
- 4 Open-market sale Director sold 96 shares at $7.16 ($687)
- 4 Open-market sale Chief Scientific Officer sold 5,022 shares at $7.42 ($37,263)
- 4 Open-market sale Chief Information Officer sold 5,022 shares at $7.42 ($37,263)
- 4 Open-market sale Chief Data Officer sold 4,333 shares at $7.42 ($32,151)
- 4 Open-market sale Chief Executive Officer sold 12,327 shares at $7.42 ($91,466)
- 4 Open-market sale Director sold 101 shares at $7.42 ($749)
- 4 Open-market sale General Counsel sold 5,022 shares at $7.42 ($37,263)
- 4 Open-market sale Chief Financial Officer sold 6,760 shares at $7.42 ($50,159)
- 4 Grant or award Director acquired 7,117 shares (grant or award)
- 4 Open-market sale Chief Executive Officer sold 26,867 shares at $8.11 ($217,891)
- 4 Open-market sale Chief Financial Officer sold 5,415 shares at $8.11 ($43,916)
- 4 Grant or award Director acquired 7,117 shares (grant or award)
Page 9 of 16 · 313 filings